Rheumatology Doctors in Round Rock, TX Accepting Medicare

6 Rheumatology doctors found. Showing 1 - 6

Sangeetha Pabolu, M.D. Internal Medicine - Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 425 University Blvd, Round Rock, TX 78665 Phone: 512-509-0200    Fax: 512-509-0285

Dr. Darush Rahmani, D.O. Internal Medicine - Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 940 Hesters Crossing Rd, Round Rock, TX 78681 Phone: 512-244-9024    Fax: 512-406-7342

Dr. Olga V Szalasny, MD Internal Medicine - Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 425 University Blvd, Round Rock, TX 78665 Phone: 512-509-0200

Sindu Yenigalla, Internal Medicine - Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 425 University Blvd, Round Rock, TX 78665 Phone: 125-090-2005    Fax: 512-509-0285

Nada Elmagboul, M.D. Internal Medicine - Rheumatology Medicare: Accepting Medicare Assignments Practice Location: Baylor Scott And White Clinic, 425 University Boulevard, Round Rock, TX 78665 Phone: 512-509-0200    Fax: 512-509-0285

Dr. Allyson Kristen Mcdonough, MD Internal Medicine - Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 302 University Blvd, Round Rock, TX 78665 Phone: 512-509-0200    Fax: 512-218-6330

News Archive

Medicare must change the way that it values and reimburses physician services

...to prevent a collapse of primary care medicine in the U.S., the president of the American College of Physicians (ACP) told the House Ways and Means Subcommittee on Health.

Majority of U.S. physicians say patients have difficulty paying for medications and care

Fifty-eight percent of primary care doctors in the U.S. report their patients often have difficulty paying for medications and care, and half of U.S. doctors spend substantial time dealing with restrictions insurance companies place on their patients' care, according to findings from the 2009 Commonwealth Fund International Health Policy Survey published online today in the journal Health Affairs.

Study supports use of EndoBarrier Therapy for patients with type 2 diabetes and obesity

GI Dynamics, Inc. today announced findings from a new meta-analysis which describes the increasingly robust efficacy and safety profile of EndoBarrier Therapy, an endoscopically-delivered device therapy approved for the treatment of type 2 diabetes and obesity.

New actinic keratoses data presented at the 15th World Congress of Cancers of the Skin

New data from the international FIELD Study Repeat presented today at the 15th World Congress of Cancers of the Skin (WCCS) in Edinburgh, Scotland, demonstrate initial treatment with Picato® (ingenol mebutate gel) 0.015% is efficacious in treating actinic keratoses (AK) and, when followed by a repeat cycle for persistent and newly emerging AKs, this efficacy is further increased.1 The data also confirm two treatment cycles of Picato® are well tolerated by patients.2

Thoratec board authorizes repurchase of additional $50M of common stock

Thoratec Corporation, a world leader in device-based mechanical circulatory support therapies to save, support and restore failing hearts, announced today that its Board of Directors has authorized the repurchase of an additional $50 million of the company's shares of common stock over the next year.

Read more Medical News

› Verified 7 days ago